GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$308M
AUM Growth
+$68.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1 +$25.5M
2 +$21.1M
3 +$18M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$9.87M
5
SLNO icon
Soleno Therapeutics
SLNO
+$9.6M

Top Sells

1 +$14.9M
2 +$12.7M
3 +$11.8M
4
CYTK icon
Cytokinetics
CYTK
+$8.24M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$8.03M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGE icon
1
Apogee Therapeutics
APGE
$5.14B
$28.2M 9.15%
374,000
+70,000
AMLX icon
2
Amylyx Pharmaceuticals
AMLX
$1.64B
$21.1M 6.85%
1,750,000
+50,000
ZURA icon
3
Zura Bio
ZURA
$663M
$20M 6.48%
3,815,930
IRON icon
4
Disc Medicine
IRON
$2.44B
$19.9M 6.44%
+250,000
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$19.7M 6.38%
+581,187
IMVT icon
6
Immunovant
IMVT
$5.2B
$19.1M 6.18%
750,000
+250,000
SLNO icon
7
Soleno Therapeutics
SLNO
$2.02B
$18.5M 6%
400,000
+175,000
VOR icon
8
Vor Biopharma
VOR
$618M
$17.9M 5.81%
+1,370,107
DNTH icon
9
Dianthus Therapeutics
DNTH
$3.71B
$14.4M 4.68%
350,000
+84,197
JBIO
10
Jade Biosciences
JBIO
$691M
$12.4M 4.03%
806,273
+173,674
KALV icon
11
KalVista Pharmaceuticals
KALV
$922M
$11.1M 3.59%
+685,632
CTNM
12
Contineum Therapeutics
CTNM
$547M
$9.14M 2.96%
+800,000
EPRX
13
Eupraxia Pharmaceuticals
EPRX
$448M
$9.06M 2.94%
1,200,000
FULC icon
14
Fulcrum Therapeutics
FULC
$519M
$9.05M 2.93%
+800,000
NKTR icon
15
Nektar Therapeutics
NKTR
$2.05B
$8.91M 2.89%
210,732
-89,268
UPB
16
Upstream Bio Inc
UPB
$506M
$8.14M 2.64%
300,000
NGNE icon
17
Neurogene
NGNE
$357M
$7.21M 2.34%
350,000
-96,814
RARE icon
18
Ultragenyx Pharmaceutical
RARE
$2.15B
$6.9M 2.24%
+300,000
CNTX icon
19
Context Therapeutics
CNTX
$291M
$6.89M 2.23%
4,683,711
CGEM icon
20
Cullinan Oncology
CGEM
$845M
$6.56M 2.13%
+634,032
EVMN
21
Evommune Inc
EVMN
$738M
$5.56M 1.8%
+325,000
ORKA
22
Oruka Therapeutics
ORKA
$1.67B
$5.56M 1.8%
183,330
SLN
23
Silence Therapeutics
SLN
$330M
$4.91M 1.59%
+808,032
UNCY icon
24
Unicycive Therapeutics
UNCY
$151M
$4.6M 1.49%
796,558
CLYM
25
Climb Bio
CLYM
$350M
$3.92M 1.27%
+979,534